• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    CytRx Corporation (CYTR)

    -NasdaqCM
    2.57 Down 0.08(3.02%) Jan 30, 4:00PM EST
    Add to Portfolio
    Prev Close:2.65
    Open:2.63
    Bid:N/A
    Ask:2.90 x 3500
    1y Target Est:12.00
    Beta:0.95
    Next Earnings Date:N/A
    Day's Range:2.55 - 2.69
    52wk Range:2.08 - 7.23
    Volume:659,159
    Avg Vol (3m):1,317,040
    Market Cap:143.24M
    P/E (ttm):N/A
    EPS (ttm):-0.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYTR

    Comparison

    Symbol% ChgMkt Cap
    CYTRDown 3.02%143.24M
    LLYDown 0.15%77.01B
    NVSDown 1.77%233.63B
    SNYDown 1.94%120.95B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,477.00
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.73
    Quarterly EPS Est (Dec-14) :-0.26
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate includes aldoxorubicin that has completed Phase IIb clinical trial as a first-line therapy for soft t... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback